Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell entry receptors are a broad category of cell surface molecules, including proteins, carbohydrates, and lipids, that viruses exploit to initiate infection (Maginnis, 2018). These molecules are functionally divided into attachment factors, which facilitate the initial docking of the virus to the cell surface, and entry receptors, which actively trigger viral internalization via membrane fusion or endocytosis (Shulla & Gallagher, 2009). The description 'viral attachment only' typically refers to attachment factors like heparan sulfate or sialic acid, which concentrate viral particles but do not independently mediate entry. These are often considered 'non-classical' drug targets because they are ubiquitous or have vital physiological roles that make them difficult to inhibit without significant side effects (Cagno et al., 2019). Therapeutic strategies targeting these receptors include small molecule inhibitors, monoclonal antibodies, and decoy molecules designed to block the interaction between the virus and the host cell (Hoffmann et al., 2020). Understanding the specific host factors required for different viruses is crucial for developing both broad-spectrum and virus-specific entry inhibitors.
Inhibition of viral infection by blocking the interaction between viral surface proteins (e.g., spike, gp120) and host cell surface molecules, thereby preventing viral attachment, fusion, or endocytosis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell entry receptor.